Equine Encephalitis Virus Vaccine: Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial
by Press Release from Outbreak News Today on (#4S4R8)
Bavarian Nordic A/S announced today the initiation of the first-in-human trial of MVA-BN(R) WEV, a prophylactic vaccine candidate against the equine encephalitis virus - a rare, but potentially deadly illness. The program, which is funded by the United States Department of Defense (DOD) Joint Project Manager for Chemical, Biological, Radiation, and Nuclear Medical (JPM CBRN Medical) ["]
The post Equine Encephalitis Virus Vaccine: Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial appeared first on Outbreak News Today.